Tower Research Capital LLC (TRC) - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$145,564
+1897.6%
10,390
+1375.9%
0.01%
Q2 2023$7,287
+45443.8%
704
-60.4%
0.00%
-100.0%
Q1 2023$16
+6.7%
1,778
+2.1%
0.00%0.0%
Q4 2022$15
-99.9%
1,741
-26.8%
0.00%
Q3 2022$20,000
-4.8%
2,378
-5.4%
0.00%
Q2 2022$21,000
+133.3%
2,513
+130.8%
0.00%
Q1 2022$9,000
-57.1%
1,089
-50.6%
0.00%
Q4 2021$21,000
+110.0%
2,205
+267.5%
0.00%
Q3 2021$10,000
-80.0%
600
-81.8%
0.00%
-100.0%
Q2 2021$50,000
-43.2%
3,294
-27.6%
0.00%0.0%
Q1 2021$88,000
-14.6%
4,550
-20.0%
0.00%
-66.7%
Q4 2020$103,000
-74.7%
5,688
-73.0%
0.00%
-40.0%
Q3 2020$407,000
+450.0%
21,096
+644.7%
0.01%
+66.7%
Q2 2020$74,000
+270.0%
2,833
+375.3%
0.00%
+50.0%
Q4 2019$20,000
-57.4%
596
-70.2%
0.00%
-33.3%
Q3 2019$47,000
+1075.0%
2,000
+1500.0%
0.00%
Q2 2019$4,000
-96.4%
125
-95.8%
0.00%
-100.0%
Q1 2019$110,000
+633.3%
2,979
+768.5%
0.01%
+600.0%
Q4 2018$15,000
-53.1%
343
-50.1%
0.00%
-50.0%
Q3 2018$32,000
+357.1%
687
+397.8%
0.00%
Q2 2018$7,000
-30.0%
138
-29.9%
0.00%
-100.0%
Q1 2018$10,0000.0%197
-38.1%
0.00%0.0%
Q3 2017$10,000
+100.0%
318
+14.0%
0.00%0.0%
Q2 2017$5,0002790.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders